SCHEMBL14478705

SCHEMBL14478705

Brc1cnc2c3ccccc3c3cc(-c4ncnc(-c5ccncc5)n4)c4ccccc4c3c2c1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ PDGFRB P09619 1/20 0.32
▸ PDGFRA P16234 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ HTT P42858 1/20 0.31
▸ GABRA1 P14867 1/20 0.31
▸ GABRG2 P18507 1/20 0.31
▸ GABRB3 P28472 1/20 0.31
▸ GABRA5 P31644 1/20 0.31
▸ GABRA3 P34903 1/20 0.31
▸ NPC1 O15118 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ PLK4 O00444 1/20 0.31
▸ AURKA O14965 1/20 0.31
▸ JAK2 O60674 1/20 0.31
▸ ROCK2 O75116 1/20 0.31
▸ PRKD3 O94806 1/20 0.31
▸ MAP4K4 O95819 1/20 0.31
▸ PRKCG P05129 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14478648 0.87 ACVR1 (0.41) MEN1KMT2APDGFRBPDGFRASMN1; SMN2
SCHEMBL14478635 0.85 KDM4E (0.35) MEN1KMT2APDGFRBPDGFRASMN1; SMN2
SCHEMBL14478619 0.83 MAPK10 (0.41) PDGFRBPDGFRAMAP4K4MAPK8CLK2
SCHEMBL14478693 0.74 DHFR (0.39) PLK4AURKAJAK2ROCK2PRKD3
SCHEMBL14478661 0.72 PDGFRB (0.44) PDGFRBPDGFRANPC1RAB9AKDR
SCHEMBL14478654 0.71 KDM4E (0.38) PDGFRBPDGFRASMN1; SMN2NPC1RAB9A
SCHEMBL14478674 0.70 KDM4E (0.40) MEN1KMT2APDGFRBPDGFRASMN1; SMN2
SCHEMBL14478662 0.69 PDGFRB (0.45) PDGFRBPDGFRAMAPK8KDM4EMAPK9
SCHEMBL14478621 0.69 L3MBTL1 (0.39) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL14478634 0.68 KDM4E (0.36) MEN1KMT2ANPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8986855-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-03-24 — — US disclosed
US-8986855-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-03-24 — — US disclosed
US-8951649-B2 — — 2015-02-10 — — US disclosed
US-8951649-B2 — — 2015-02-10 — — US disclosed
US-20130001529-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-01-03 — — US disclosed
US-20130001529-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130001529-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, ORC3, NR2E3 MEN1 358/4885KMT2A 1554/4885PDGFRB 2684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback